The Breakfast Rise, Education and Knowledge Study (BREAK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05698875
Recruitment Status : Not yet recruiting
First Posted : January 26, 2023
Last Update Posted : January 26, 2023
Sponsor:
Information provided by (Responsible Party):
University of Stirling

Brief Summary:
The study proposes to recruit 90 children and young people who have type 1 diabetes (T1D) and who regularly use Dexcom continuous glucose monitoring (CGM). The participants will be recruited from National Health Service (NHS) sites in the United Kingdom (UK) via their managing dietitian. The dietitian will be asked to provide baseline information about the participants which will include demographic data and information on clinical data, treatment and anthropometrics. Participants will be asked to provide access to Dexcom CGM data throughout the period of recording. Participants will be asked to test three breakfast meals (high glycaemic load, high glycaemic with 10g added protein and medium glycaemic load) plus a control meal (usual breakfast), repeating each meal twice in a randomized order using a Latin square randomisation. The dietitian will be asked to optimise the participants insulin doses prior to commencing test meals. Participants will be asked to complete a questionnaire for each of the postprandial test and control meal periods. This will include questions about their diabetes management, food and fluid intake in addition to questions on activities all of which took place during the three-hour postprandial period. The glycaemic response to the test and control meals will be analysed using the CGM data and the results statistically described using univariate, bivariate and multivariate analysis.

Condition or disease Intervention/treatment Phase
type1diabetes Other: High glycaemic load breakfast meal Other: High glycaemic load breakfast meal with additional 10g protein Other: Medium glycaemic load breakfast meal Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: Participants will be randomised to test each of the three test meals on two separate occasions with a control meal (usual breakfast meal) for each test meal. Randomisation will be achieved using a Latin square randomisation. The tool used for this will be http://www.jerrydallal.com/random/randomize.htm. Randomisation will be done in a block of four.
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: The Breakfast Rise, Education and Knowledge Study in Children and Young People Who Have Type 1 Diabetes (T1D): The BREAK Study
Estimated Study Start Date : February 2023
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : August 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Diabetes Type 1

Arm Intervention/treatment
Test meal 1
High glycaemic load breakfast meal
Other: High glycaemic load breakfast meal
Breakfast meal

Test meal 2
High glycaemic lead with additional 10g protein breakfast meal
Other: High glycaemic load breakfast meal with additional 10g protein
Breakfast meal

Test meal 3
Medium glycaemic load breakfast meal
Other: Medium glycaemic load breakfast meal
Breakfast meal




Primary Outcome Measures :
  1. Mean glucose (mmol/l) [ Time Frame: three-hour postprandial breakfast period ]
    mmol/l


Secondary Outcome Measures :
  1. Mean peak glucose [ Time Frame: three-hour postprandial breakfast period ]
    mmol/l

  2. Mean time to peak [ Time Frame: three-hour postprandial breakfast period ]
    minutes

  3. Mean time to recover [ Time Frame: three-hour postprandial breakfast period ]
    minutes

  4. Area under the glucose curve [ Time Frame: three-hour postprandial breakfast period ]
    mmol/minute

  5. Range times (Time in range, time above range, time below range) [ Time Frame: three-hour postprandial breakfast period ]
    Percentage



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children and young people aged between 5-17 years
  • Diagnosis of type 1 diabetes for a minimum of one year
  • On multiple daily injections (MDI) together with carbohydrate counting or Continuous Subcutaneous Insulin Infusion (CSII) using either open or closed loop systems.
  • Use Dexcom continuous glucose monitoring (CGM) on a regular basis
  • Have a Dexcom Clarity account and use the Clarity App
  • Regularly eats a breakfast meal before midday
  • Access to internet and email

Exclusion Criteria:

  • Prescribed anti-hyperglycaemia agents i.e. Glucophage (Metformin) and or antidepressants.
  • Any other medical conditions that may impact on the digestion and or absorption of nutrients, including coeliac disease and gastroparesis.
  • Vegans
  • Allergic or intolerant to the test meals
  • Experiencing difficulties with food including diagnosed eating disorders
  • Currently actively taking part in another research study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05698875


Contacts
Layout table for location contacts
Contact: Julie Johnson, MNutr 07815893076 julie.johnson1@stir.ac.uk
Contact: Stuart DR Galloway, PhD 01786 466494 s.d.r.galloway@stir.ac.uk

Locations
Layout table for location information
United Kingdom
Faculty of Health Sciences and Sport
Stirling, Stirlingshire, United Kingdom, FK9 4LA
Contact: Julie Johnson, MNutr    07815893076    julie.johnson1@stir.ac.uk   
Contact: Stuart DR Galloway, PhD    01786 466494    s.d.r.galloway@stir.ac.uk   
Sponsors and Collaborators
University of Stirling
Investigators
Layout table for investigator information
Principal Investigator: Julie Johnson, MNutr University of Stirling
Publications:

Layout table for additonal information
Responsible Party: University of Stirling
ClinicalTrials.gov Identifier: NCT05698875    
Other Study ID Numbers: 316676
First Posted: January 26, 2023    Key Record Dates
Last Update Posted: January 26, 2023
Last Verified: December 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus, Type 1
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases